Impact of <i>lian gong</i> on the quality of life of individuals with dizziness in primary care

Lopes, Aline Lamas; Lemos, Stela Maris Aguiar; Figueiredo, Pedro Henrique Scheidt; Santos, Juliana Nunes

doi:10.11606/s1518-8787.2019053001234

Acessibilidade / Reportar erro

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

Original Article • Rev. Saúde Pública 53 • 2019 • https://doi.org/10.11606/s1518-8787.2019053001234 copy

Impact of lian gong on the quality of life of individuals with dizziness in primary care

Authorship SCIMAGO INSTITUTIONS RANKINGS

ABSTRACT

OBJECTIVE

To assess the effects of the lian gong practice as a rehabilitation strategy in primary health care on the quality of life and functional capacity of people with dizziness.

METHODS

Randomized controlled clinical trial. Thirty-six people, who were complaining of dizziness or vertigo without the presence of central signs and were referred by the physician of primary health care participated in the study. The individuals were randomly allocated to the three experimental conditions: lian gong group (n = 11), vestibular rehabilitation group (n = 11) and control group (n = 14). The interventions were weekly, in group, with duration of 12 sessions. The participants were evaluated before and after the intervention regarding quality of life by the 36-Item Short Form Health Survey and the functional capacity by the Short Physical Performance Battery.

RESULTS

The scores of all domains of the Short Form Health Survey increased after intervention in the lian gong group. This variation was higher than that observed in the control group for the domains functional capacity, limitation by physical aspects and general health status, and also higher than that found after the intervention in the Vestibular Rehabilitation Group regarding pain. No differences were found in the Short Physical Performance Battery.

CONCLUSIONS

Based on the results presented, lian gong improves the quality of life of individuals with dizziness, without altering the functional capacity.

Dizziness, rehabilitation; Complementary Therapies; Primary Health Care; Randomized Controlled Trial

Variable	Intervention (n = 9)	Intervention (n = 10)	Control (n = 14)	p

	(LG)	(VR)	(CG)

	Mean and standard deviation/n and relative freq. (%)	Mean and standard deviation/n and relative freq. (%)	Mean and standard deviation/n and relative freq. (%)
Sociodemographic aspects
Age^a (years)	64 (4.5)	64.7 (4.4)	61.1 (5.6)	0.20
Women^b	8 (88.8)	9 (90)	12 (85.7)	0.94
Body function and structure
Dizziness^b	9 (100)	10 (100)	14 (100)	1.00
Vertigo^b	9 (100)	10 (100)	14 (100)	1.00
Anxiety^b	9 (100)	8 (80)	11 (78.5)	0.33
Buzz^b	6 (66.6)	7 (70)	11 (78.5)	0.80
Hollow head sensation^b	7 (77.7)	5 (50)	6 (42.9)	0.24
Blurred vision sensation^b	6 (66.5)	4 (40)	6 (42.9)	0.43
Visual changes^b	7 (77.7)	9 (80)	12 (85.7)	0.75
Limitation of activities
To stumble	3 (33.3)	4 (40)	9 (64.3)	0.28
To stagger	5 (55.5)	9 (90)	12 (85.7)	0.13
To turn the foot	4 (44.4)	3 (30)	10 (71.4)	0.12
To fall	3 (33.3)	5 (50)	10 (71.4)	0.19
To not perform physical activity	5 (55.5)	6 (60)	10 (71.4)	0.71
Other health conditions
SAH	5 (55.5)	5 (50)	4 (28.6)	0.37
Diabetes	3 (33.3)	1 (10)	3 (21.4)	0.46
Depression	3 (33.3)	3 (30)	2 (14.3)	0.51
Migraine	2 (22.2)	5 (50)	2 (14.3)	0.14

Domains of SF36	Groups			Intergroups difference

	Lian gong (LG)	Vestibular rehabilitation (VR)	Control (CG)	LG versus CG	VR versus CG	LG versus VR
General health status
Pre	81.4 (3.2)	81.7 (4.6)	80.5 (1.7)	0.94 (-1.1–3.0)	1. 2 (-1.5–3.9)	0.25 (4.2–3.6)
Post	84.8 (4.1)	83.1 (4.8)	80.5 (1.5)	4.3 (1.7–6.8)^a	2.5 (-0.34–5.4)	1.7 (-2.5–6.1)
≠ intragroups	3,44 (0,7–6,1)^a,b,c	1,4 (0,01–2,7)^a	0,71 (-0,5–0,6)
Functional capacity
Pre	69.7 (7.3)	67.4 (6.3)	71.8 (7.1)	-2.0 (-8.5–4.3)	- 4.4 (-10.3–2.8)	2.3 (-4.2–8.9)
Post	72.8 (7.1)	69.2 (6.3)	71.6 (6.9)	0.91 (-5.3–7.1)	-2.4 (-8.1–3.3)	3.3 (-3.3–9.8)
≠ intragroups	2.77 (1.2–4.3)^a.b	1.8 (-0.5–4.1)	-0.21 (-1.3–0.8)
Limitation by physical aspects
Pre	82.7 (4.2)	80.9 (4.2)	81. 0 (4.4)	1.8 (-2.1–5.7)	-0.1 (-3.8–3.6)	1.8 (-2.2–6.0)
Post	84.3 (4.5)	82.4 (5.2)	80.5 (4.8)	2.0 (-0.47–7.9)	1.8 (-2.5–6.1)	1.9 (-2.8–6.7)
≠ intragroups	1.5 (0.3–2.7)^a.b	1.5 (0.2–2.7)^a.b	-0.42 (-1.4–0.5)
Pain
Pre	78.4 (5.3)	79.0 (5.8)	81.2 (3.0)	-2.8 (-6.4–0.8)	-2.2 (-6.0–1.4)	-0.55 (-5.9–4.8)
Post	8.18 (4.8)	77.3 (8.3)	81.2 (2.9)	0.67 (-2.6–4.0)	-3.9 (-8.8–1.0)	4.5 (-2.1–11.2)
≠ intragroups	3.4 (0.8–6.0)^a.c	-1.7 (-6.7–3.3)	-0.07 (-0.9–0.7)
Vitality
Pre	60.3 (4.1)	59.9 (3.2)	61.5 (2.8)	1.4 (-4.1–1.8)	-1.6 (-4.1–0.97)	0.43 (-3.1–4.0)
Post	63.3 (5.0)	62.7 (5.0)	62.1 (2.5)	1.1 (-2.1–4.4)	0.55 (-2.6–3.8)	0.63 (-4.2–5.5)
≠ intragroups	3.0 (0.9–5.0)^a	2.8 (0.4–5.1)^a	0.64 (-0.1–1.4)
Social aspects
Pre	75.1 (2.8)	76.0 (2.8)	76.2 (3.8)	- 1.1 (-4.2–2.0)	-0.21 (-3.2–2.7)	-0.88 (-3.6–1.8)
Post	76.5 (4.4)	79.6 (3.7)	76.5 (4.4)	0.5 (-2.7–3.7)	3.1 (-0.47–6.6)	-2.6 (-5.5–0.35)
≠ intragroups	1.8 (0.4–3.3)^a	3.6 (1.0–6.1)^a.b	0.28 (-0.9–1.4)
Emotional aspects
Pre	74.3 (5.2)	75.1 (5.1)	72.2 (4.1)	2.1 (-1.9–6.1)	2.8 (-1.0–6.8)	–0.76 (-5.8–4.2)
Post	76.1 (5.6)	76.0 (4.9)	72.3 (4.6)	3.7 (-0.7–8.2)	3.6 (-0.46–7.7)	0.11 (–5.0–5.2)
≠ intragroups	1.7 (0.2–3.3)^a	0.9 (-1.1–2.9)	0.14 (-0.5–0.8)
Mental health
Pre	71.2 (3.9)	73.6 (6.1)	70.5 (5.4)	0.72 (-3.6–5.1)	3.1 (-1.8–8.0)	-2.3 (-7.4–2.6)
Post	73.3 (2.7)	74.1 (6.9)	70.8 (5.4)	2.47 (-1.5–6.5)	3.2 (-1.9–8.4)	-0.7 (-6.0–4.4)
≠ intragroups	2.11 (0.2–3.9)^a	0.5 (-2.5–3.5)	0.35 (-2.0–2.7)

Faculdade de Saúde Pública da Universidade de São Paulo Avenida Dr. Arnaldo, 715, 01246-904 São Paulo SP Brazil, Tel./Fax: +55 11 3061-7985 - São Paulo - SP - Brazil
E-mail: revsp@usp.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] Correspondence: Juliana Nunes Santos Rua Zulmiro Ramos de Almeida,45, Centro 39.100-000 Diamantina, MG, Brasil E-mail: jununessantos@yahoo.com.br